openPR Logo

Press Releases from Enamine Ltd (4 total)

Enamine Ltd. Released Coronavirus Library to Support COVID-19 Research Programs

A preplated library of 16800 compounds designed for the discovery of new SARS-CoV-2 and pan-Coronavirus antivirals KIEV, Ukraine --Enamine Ltd., a leading chemical research organization and producer of the world’s largest collections of novel building blocks (225,000+) and screening compound libraries (2,740,000+), today announced the release of the Coronavirus Library. The new screening library capitalizes on Enamine’s decades of chemical R&D, advanced library design expertise, and experience with creating focused antiviral

Enamine and Chemspace collaborate with Blue Dolphin Lead Discovery to expand Dru …

Kyiv, Ukraine and San Francisco, USA, 5 May, 2020. Today Enamine, a leading provider of small molecules and drug discovery services, Chemspace, an online catalog with the largest offer of small molecules to search and buy, and Blue Dolphin Lead Discovery, a research organization focused on a feefor-service virtual screening, announced the launch of the collaboration to support drug discovery projects. The collaboration will include participation in the joint projects related

Enamine to be the exclusive supplier of Astex's MiniFrag Library

Enamine Ltd., a premier supplier of Building Blocks, Fragments and Screening Compounds, and Astex Pharmaceuticals (UK), a prominent biotech company focused on discovery and development of innovative medicines targeting cancer and CNS disorders, have cooperated to provide wide access to Astex's MiniFrag library, an efficient Fragment-based Drug Discovery tool for identification of hot and warm spots of protein targets. The concept recently proposed by Astex (O'Reilly, Drug Discovery Today, 2019

Cyclica Collaborates With Enamine to Use REAL Technology in Its Ligand Design Pl …

TORONTO & KYIV, UKRAINE. Cyclica, Inc. announced a collaboration with Enamine Ltd., the world’s largest chemical supplier, to explore its huge readily accessible chemical space using Cyclica’s state-of-the-art AI-driven Ligand DesignTM platform. The companies aim to empower Cyclica’s patented, evolutionary algorithm with new design options based on the 73,000 Enamine’s in-stock building blocks and 171 thoroughly validated synthesis procedures. The joint effort is expected to enable Cyclica’s Ligand DesignTM to

Go To Page:   1 2 3 4 5 6 7 8 9 10